P-137 - PHARMACOGENETIC INFLUENCE OF CYP2C19 VARIATION ON ESCITALOPRAM PHARMACOKINETICS IN CHILDREN AND ADOLESCENTS.

E. Poweleit^1,2, S. Vaughn^3,1, Z. Desta⁴, J. Strawn^1,2, L. Ramsey^3,1; ¹University of Cincinnati, Cincinnati, OH, USA, ²Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA, ³Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA, ⁴Indiana University, Indianapolis, IN, USA.